Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    The Case of the Cord Blood Match
    Clinical practice
    The Case of the Cord Blood Match
    March 26, 2021
    Empower Recent Graduate Nurses to Be Patient Advocates
    Nurse empowerment
    Empower Recent Graduate Nurses to Be Patient Advocates
    March 19, 2021
    Shared Governance Committees Empower Nurses to Use Their Voice
    Nurse empowerment
    Shared Governance Committees Empower Nurses to Use Their Voice
    March 12, 2021
    Nursing Students Connect Beyond the Classroom With ONS Resources
    Nursing education
    Nursing Students Connect Beyond the Classroom With ONS Resources
    March 05, 2021
    COVID-19 Affects Cancer Caregivers, but Here Are Ways to Support Them
    COVID-19
    COVID-19 Affects Cancer Caregivers, but Here Are Ways to Support Them
    February 19, 2021
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Research

    Press Releases

    Oncology Nursing Foundation Refocuses Commitment to All Oncology Nurses

    Support for oncology nursing is critical to the advancement of the profession and the future of care for patients with cancer. The Oncology Nursing Foundation—formerly known as the Oncology Nursing Society (ONS) Foundation—is a nonprofit, tax-exempt, charitable organization dedicated solely to supporting oncology nurses both nationally and internationally. Today, the Foundation announced its name change to wholly encapsulate the organization’s longstanding focus and goals. Through continuing education scholarships, research grants, and career development funding, the Oncology Nursing Foundation supports oncology nurses in their pursuits to provide safer and more effective cancer care for their patients. 

    November 13, 2018
    JADPRO Live

    Psychosocial Support May Reduce Stigma for Patients With Lung Cancer

    Because of the relationship between cigarette smoking and lung cancer, patients who receive a lung cancer diagnosis may feel judgment compared to patients with other cancer diagnoses, which could affect social interactions between family, caregivers, and healthcare professionals. Perceived lung cancer stigma can lead to depression, anxiety, poor self-esteem, guilt, shame, blame, poor social identity, and reduced social support. A recent study indicated that lung cancer stigma might be behind the low lung cancer screening rates among high-risk smokers.

    November 13, 2018
    Tailored Psychotherapy Combats Depression in Advanced Cancer
    Psychosocial issues

    Tailored Psychotherapy Combats Depression in Advanced Cancer

    Just three to six sessions of a tailored psychotherapy program called CALM, or Managing Cancer and Living Meaningfully, reduced symptoms of depression or prevented the onset of depression in patients with recently diagnosed advanced cancer, according to findings from a study published in the Journal of Clinical Oncology.

    November 07, 2018
    JADPRO Live

    Advance Care Planning Initiative Promotes Patient Preference

    Advance care planning (ACP) involves communication with the patient, his or her family and/or caregivers, and the healthcare team to plan for the future and promote shared decision making that incorporates patient preferences. Guidelines from the American Society of Clinical Oncology and National Comprehensive Cancer Network recommend that ACP discussions take place within three months of a diagnosis of incurable cancer; however, ACP conversations may not occur because patients, family members, and providers each wait for the other to initiate the discussion.

    November 02, 2018
    President Trump Enacts FY 2019 Labor/HHS Funding Package for Nursing and Cancer Research
    Research

    President Trump Enacts FY 2019 Labor/HHS Funding Package for Nursing and Cancer Research

    Budget season on Capitol Hill is always a complicated time. It’s a tug-of-war between funding priorities and fiscal responsibility. Often, budget debates end up in a stalemate and the government shuts down. However, for the first time in 22 years, the president signed the fiscal year 2019 Labor Department of Health and Human Services Appropriations package before the September 30 budget deadline.

    November 02, 2018
    Liquid Biopsy May Predict Breast Cancer Late Recurrence
    Breast cancer

    Liquid Biopsy May Predict Breast Cancer Late Recurrence

    Liquid biopsies—blood tests that detect circulating tumor cells—may help healthcare providers predict which women with hormone receptor-positive (HR+) breast cancer are at higher risk of recurrence, according to the results of a study published in JAMA Oncology.

    October 24, 2018
    ONS Member Featured in NCI Supportive and Palliative Care Research Video
    National Cancer Institute (NCI)

    ONS Member Featured in NCI Supportive and Palliative Care Research Video

    The National Cancer Institute (NCI) released a short video featuring ONS member Ann O’Mara, PhD, RN, MPH, program director in the NCI’s Division of Cancer Prevention. She speaks directly about research  projects focusing on supportive and palliative care for patients with cancer. O’Mara specifically highlights a recent study determining the impact of acupuncture on pain for patients with cancer.

    October 22, 2018
    NCI Releases Annual Strategic Plan and Budget Proposal
    National Cancer Institute (NCI)

    NCI Releases Annual Strategic Plan and Budget Proposal

    Every federal agency is required to submit a plan and proposal to Congress outlining its budget for the next fiscal year—or years—as well as justifications for how and why the department needs the requested allotment. In September 2018, the National Cancer Institute (NCI) released its Annual Plan and Budget Proposal for Fiscal Year 2020.

    October 20, 2018
    Neuroendocrine Prostate Cancer Subtype Is Aggressive and More Common Than Expected
    Research

    Neuroendocrine Prostate Cancer Subtype Is Aggressive and More Common Than Expected

    Nearly 20% of men with metastatic, castration-resistant prostate cancer had tumors that developed into the treatment-emergent small-cell neuroendocrine (t-SCNC) subtype, which is associated with shorter survival than other subtypes, according to findings from a study published in the Journal of Clinical Oncology.

    October 17, 2018
    FDA Approves Talazoparib for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
    U.S. Food and Drug Administration (FDA)

    FDA Approves Talazoparib for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer

    On October 16, 2018, the U.S. Food and Drug Administration (FDA) approved talazoparib, a poly (ADP-ribose) polymerase inhibitor, for patients with deleterious or suspected deleterious germline BRCA-mutated, HER2‑negative locally advanced or metastatic breast cancer. Patients must be selected for therapy based on an FDA-approved companion diagnostic for talazoparib.

    October 16, 2018
    U.S. Pediatric Cancer Incidence Varies by Geography
    Research

    U.S. Pediatric Cancer Incidence Varies by Geography

    A new study demonstrated that pediatric cancer rates vary by U.S. state and geographic region, with the highest rates in the Northeast, specifically New Hampshire; Washington, DC; and New Jersey. The study findings were published in Morbidity and Mortality Weekly Report.

    October 10, 2018
    Further Research Can Help Nurses Balance Cardiovascular Conditions With Cancer Treatments
    Research

    Further Research Can Help Nurses Balance Cardiovascular Conditions With Cancer Treatments

    As the leading cause of death for adult Americans, cardiovascular disease is a complication found in many patients with cancer. Many cancer treatments have the potential to impact existing cardiac comorbidities or develop new cardiovascular conditions in patients undergoing treatment. Understanding and recognizing this issue is paramount for oncology nurses and is the focus of current research efforts impacting clinical practice. 

    October 09, 2018
    Oncology Nurse Appointed to PCORI Board of Governors
    Research

    Oncology Nurse Appointed to PCORI Board of Governors

    As the U.S. government’s arm of patient-centered research, the Patient-Centered Outcomes Research institute (PCORI) is driving new initiatives and opportunities focused on unlocking novel treatment methods and cutting-edge interventions to better care for patients. On September 24, 2018, PCORI announced its new Board of Governors, naming ONS member Christopher Friese, PhD, RN, AOCN®, FAAN, as the agency’s first nursing research representative to hold a seat on the board.

    October 03, 2018
    Ketogenic Diet May Overcome Drug Resistance With PI3K Inhibitors
    Treatments

    Ketogenic Diet May Overcome Drug Resistance With PI3K Inhibitors

    Researchers have shown in mouse models that using PI3K inhibitor targeted therapy along with a ketogenic diet may help prevent or overcome the drug resistance that can eventually occur. The findings were reported in Nature.

    October 03, 2018
    Biden Cancer Summit; PCORI Governing Board; Low-Income Smokers
    Cancer moonshot

    Biden Cancer Summit; PCORI Governing Board; Low-Income Smokers

    The Biden Cancer Summit was held in Washington, DC, on September 21, 2018. The day-long event was filled with cancer-related educational sessions—some hosted by ONS leadership—discussing ways to move cancer research and care forward. Formerly dubbed the National Cancer Moonshot Initiative, the country-wide effort to make a quantum leap in cancer care has evolved in into the Biden Cancer Initiative (BCI). BCI’s ongoing work will continue to break down barriers and help providers and researchers overcome obstacles as they work toward progress in cancer care.

    October 01, 2018
    Breast Cell Layer Keeps Cancer From Metastasizing
    Breast cancer

    Breast Cell Layer Keeps Cancer From Metastasizing

    Researchers have discovered that breast myoepithelium cells actively work to keep breast cancer cells from spreading throughout the body. The findings were reported in the Journal of Cell Biology.

    September 26, 2018
    Deborah Watkins Bruner
    Research

    Emory University Appoints Oncology Nurse as Senior Vice President of Research

    Building on a long career as a pioneer in oncology nursing research and cancer clinical trials, ONS member Deborah Watkins Bruner, RN, PhD, FAAN, has been named the senior vice president of research at Emory University in Atlanta, GA, a newly created position that serves on the Emory president’s leadership team. Effective October 1, 2018, Bruner’s leadership, expertise, and research experience will guide Emory’s interprofessional research efforts and promote education and training for future researchers, including nurse scientists.

    September 24, 2018
    Moonshot Moves Forward Thanks to Biden Initiative
    Cancer moonshot

    Moonshot Moves Forward Thanks to Biden Initiative

    Like all great adventures, it began as an idea. What if the United States could make huge advancements in the fight against cancer in a short amount of time? How could that be accomplished? What are the metrics? How much would it cost? Who could direct such an effort? 

    September 19, 2018
    Older Patients Respond Better to Checkpoint Inhibitors for Melanoma
    Melanoma

    Older Patients Respond Better to Checkpoint Inhibitors for Melanoma

    Patients aged 62 and older are more likely to respond to immune checkpoint inhibitors for melanoma, such as pembrolizumab, according to findings from a study published in Clinical Cancer Research. A follow-up study showed that it may be because of age-related changes in the immune cells in melanoma tumors.

    September 19, 2018
    Global Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Deaths in 2018
    Research

    Global Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Deaths in 2018

    As global populations grow, so does the cancer burden, a new study from the World Health Organization’s International Agency for Research on Cancer (IARC) reported. The results of the latest analysis of the incidence and mortality of 36 types of cancer in 185 countries were published in CA: A Cancer Journal for Clinicians in September 2018.

    September 13, 2018
    VA and NCI Collaborate on Access to Cancer Clinical Trials
    National Cancer Institute (NCI)

    VA and NCI Collaborate on Access to Cancer Clinical Trials

    A new cross-government program is underway to improve veterans’ access to clinical cancer trials. Together with the National Cancer Institute (NCI), the Department of Veterans Affairs (VA) Interagency Group to Accelerate Trials Enrollment launched in 12 VA facilities in summer 2018.

    September 12, 2018
    NIH Launches Study Focused on Prostate Cancer Rates in African American Men
    Prostate cancer

    NIH Launches Study Focused on Prostate Cancer Rates in African American Men

    To better understand environmental and genetic impacts associated with prostate cancer in African American men, the National Institutes of Health (NIH) began a new study, Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress (RESPOND). The research program has received more than $26 million in funding and seeks to understand why African American men have disproportionally higher rates of aggressive prostate cancer than any other racial or ethnic population.

    September 12, 2018
    “It Prevents Cancer” May Be Key to HPV Vaccine Communication
    Cancer prevention

    “It Prevents Cancer” May Be Key to HPV Vaccine Communication

    In 2016, only 43% of U.S. adolescents had received routine human papillomavirus (HPV) vaccinations. Findings from a new study published in Cancer Epidemiology, Biomarkers, and Prevention indicate that the type of strategy providers use to communicate the need for the vaccine may influence parents’ choices.

    September 12, 2018
    How Inhaled Cannabis May Contribute to Pulmonary Toxicity in Patients With Cancer
    Clinical practice

    How Inhaled Cannabis May Contribute to Pulmonary Toxicity in Patients With Cancer

    As medical use of cannabis is increasingly legalized across the United States, oncology nurses need to become more familiar with the implications of patients using it for cancer symptom management. According to Merkle and Tavernier in their article in the August 2018 issue of the Clinical Journal of Oncology Nursing, little research has been conducted in medical cannabis use and the efficacy and toxicity of cancer treatment. Their article reviewed current literature to better understand the effects that cannabis may have on the lungs in patients with cancer.  

    September 11, 2018
    What the Research Says About Supporting Cancer Survivors in Non-Oncology Settings
    Oncology nurse researcher

    What the Research Says About Supporting Cancer Survivors in Non-Oncology Settings

    In 2016, the American Cancer Society (ACS) reported that the number of currently living cancer survivors is estimated at 15.5 million Americans. For 2018, ACS is projecting another 1.7 million new cases of cancer diagnoses. On one hand, the growing number of survivors indicates that early diagnosis, new technologies, targeted interventions, treatment options, and access to care are making a huge difference for patients. 

    September 06, 2018
    Longstanding NINR Director Retires After Two Decades of Developing Nursing Science
    Research

    Longstanding NINR Director Retires After Two Decades of Developing Nursing Science

    Patricia Grady, RN, PhD, FAAN, has defined a generation of nurse science and patient-centered research, serving as the National Institute of Nursing Research (NINR) director for more than 23 years. Under her charge, NINR has grown into one of the foremost federal agencies supporting the scope of the nursing research community, driving groundbreaking initiatives and furthering clinical practice.

    August 31, 2018
    HPV Test May Be Better Than Pap Test for Women Older Than 30
    Cancer screening

    HPV Test May Be Better Than Pap Test for Women Older Than 30

    Pap tests have long been the gold standard to screen women for cervical cancer, but a new study published in JAMA says that in women older than 30 years, HPV testing is less invasive and more accurate.  

    August 30, 2018
    Recommended Surveillance Periods May Be Incorrect for Gynecologic Cancers
    Research

    Recommended Surveillance Periods May Be Incorrect for Gynecologic Cancers

    Standardized surveillance recommendations may be too short for patients with ovarian cancer and too long for other gynecologic cancers, according to findings from a study presented at the 2018 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

    August 22, 2018
    Use the Evidence to Support Physical Activity During and After Cancer Treatment
    Nursing evidence-based practice

    Use the Evidence to Support Physical Activity During and After Cancer Treatment

    We’re familiar with the evidence: being active is better for all of us throughout our lives. In fact, regular physical activity is one of the most important things we can do for our health, according to the Centers for Disease Control and Prevention. Physical activity can help to control our weight and reduce our risk of cardiovascular disease, type 2 diabetes, and some cancers. 

    August 21, 2018
    Care Coordination Standardizes Monitoring for Patients Prescribed Oral Cancer Agents
    Oral adherence

    Care Coordination Standardizes Monitoring for Patients Prescribed Oral Cancer Agents

    Use of oral therapies requires healthcare teams to monitor patients for issues such as unreported side effects, medication nonadherence, and incorrect administration of medications. Although many patients do very well with this form of treatment, some patients, even with a significant amount of education before starting therapy, may have challenges. 

    August 20, 2018
    Study Finds Association Between Increased BMI and Lower Breast Cancer Risk in Young Women
    Research

    Study Finds Association Between Increased BMI and Lower Breast Cancer Risk in Young Women

     Young women with high body fat have a decreased chance of developing breast cancer before menopause, according to a new study published in JAMA Oncology. The finding may help researchers better understand the role obesity plays in breast cancer risk.

    August 15, 2018
    Men May Have Greater Survival Benefit From Immune Checkpoint Inhibitors
    Immunotherapy

    Men May Have Greater Survival Benefit From Immune Checkpoint Inhibitors

    Researchers have found a significant difference in overall survival in men versus women receiving immune checkpoint inhibitors for advanced cancers. The findings from the systematic review and meta-analysis were reported in Lancet Oncology.

    August 08, 2018
    Annual Cancer Report Shows New Trends in Prostate Cancer
    Prostate cancer

    Annual Cancer Report Shows New Trends in Prostate Cancer

    After years of decline, the death rate trend for prostate cancer has stabilized from 2013–2015, according to the National Cancer Institute’s (NCI’s) 2018 Annual Report to the Nation on the Status of Cancer.

    August 01, 2018
    How Is CTCAE Improving Research and Patient Care?
    Oncology clinical trials

    How Is CTCAE Improving Research and Patient Care?

    The Common Terminology Criteria for Adverse Events (CTCAE) is a list of adverse event (AE) terms most often encountered in oncology. It’s been in ongoing development since the 1980s and was previously referred to as the Common Toxicity Criteria. Through continual development and support from the National Cancer Institute’s Cancer Therapy Evaluation Program, CTCAE aids in the documentation and analysis of adverse events in oncology-related clinical trials.  

    August 01, 2018
    Is Palliative Care the Answer to the Medical Aid in Dying Discussion?
    Palliative care

    Is Palliative Care the Answer to the Medical Aid in Dying Discussion?

    Oncology nurse scientists have pioneered efforts in symptom management research, including palliative and end-of-life care studies. Healthcare providers and researchers have strong consensus that palliative interventions should begin at the time of diagnosis for patients with cancer. The Clinical Journal of Oncology Nursing and Oncology Nursing Forum have published excellent articles in nearly every issue on topics of palliative care, quality of life, and symptom management issues. 

    July 18, 2018
    What Does the Research Say About Probiotics and Health?
    Complementary therapy

    What Does the Research Say About Probiotics and Health?

    Probiotics are live microorganisms that can offer health benefits following consumption, by reversing dysbiosis: changes in the composition or function of gut microbes associated with the development of many chronic and degenerative diseases. The majority of probiotics contain nonvirulent, lactic acid-producing bacteria, including Lactobacillus, Streptococcus, Bifidobacterium, Propionibacterium, and Enterococcus, or yeasts such as Saccharomyces boulardii. They are available as dietary supplements or can be obtained from yogurt and other fermented foods. Probiotics have grown in popularity over the past few decades because of perceived benefits such as improved digestion, immune function, and nutrient absorption.  

    July 16, 2018
    ONS Congress

    Nurses Are Using Quality Care to Improve Patient Outcomes

    Staying updated on advancements in cancer care increases the chances of improved outcomes for patients. Cara Henderson, RN, BSN, CMSRN, patient service manager of surgical oncology at Smilow Cancer Hospital in New Haven, CT; Elizabeth Rodriguez, DNP, RN, OCN®, nurse leader of outpatient services at Memorial Sloan Kettering Cancer Center in New York, NY, Amanda Choflet, DNP, RN, OCN®, director of nursing in radiation oncology at Johns Hopkins Health System in Baltimore, MD, and Megan Howe, MSN, RN, OCN®, nurse manager of Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center in Lebanon, NH, discussed the factors that relate to improving outcomes, the multidisciplinary approaches to the process change strategy, and the results and future direction of chosen pathways during a session at the 43rd Annual Congress in Washington, DC.

    July 11, 2018
    ONS Congress

    Genomics Is Revolutionizing Cancer Care Now and For the Future

    As precision oncology continues to expand, so does the ability to use less-toxic targeted therapies. James Chen, MD, assistant professor of biomedical informatics and assistant professor of internal medicine at the division of medical oncology at Ohio State University in Columbus, described his work with genomics in cancer care and the challenges in precision medicine at the 43rd Annual Congress in Washington, DC.

    July 11, 2018
    Communication, Organization Are Top Drivers of Oral Adherence in Clinical Trials
    Oral adherence

    Communication, Organization Are Top Drivers of Oral Adherence in Clinical Trials

    Oncology nurses know the challenges of patient adherence to oral cancer therapies. Every dose a patient misses can affect their outcomes and chance of survival. But in clinical trials, oral adherence has even broader implications: when a study is evaluating the efficacy of a drug, it depends on study participants taking it exactly as the trial outlines.

    July 10, 2018
    New Gene-Based Tests Screen and Monitor for Bladder, Endometrial, and Ovarian Cancers
    Genetics & genomics

    New Gene-Based Tests Screen and Monitor for Bladder, Endometrial, and Ovarian Cancers

    Researchers have developed two new gene-based tests that detect DNA mutations that lead to bladder, endometrial, and ovarian cancers. The tests, which are not yet U.S. Food and Drug Administration approved, could be used to identify a new or relapsed cancer earlier, when it is easier to treat.

    June 27, 2018
    Boosting T-Cell Memory Enhances Immunotherapy Effectiveness
    Immunotherapy

    Boosting T-Cell Memory Enhances Immunotherapy Effectiveness

    A combination of immunotherapies may increase the formation of memory T cells and lead to a more lasting response, according to findings from a study presented at the American Association for Cancer Research’s 2018 annual meeting.

    June 20, 2018
    Skin Bacteria May Protect Against Melanoma
    Melanoma

    Skin Bacteria May Protect Against Melanoma

    A strain of Staphylococcus epidermis that’s common on healthy human skin may be protective against some types of skin cancer, according to findings from a study published in Science Advances.

    June 13, 2018
    Animal Therapy Has Benefits for Patients—and Healthcare Staff
    Patient quality of life

    Animal Therapy Has Benefits for Patients—and Healthcare Staff

    Animal-facilitated therapy (AFT) programs have been shown to promote a healing environment and reduce certain psychological symptoms for patients with a variety of diagnoses, including cancer. Its use was even recommended by the founder of modern nursing, Florence Nightingale, who wrote about the benefits of animals in patient care and recovery: “a pet is often an excellent companion for the sick, for long chronic cases especially.”

    June 12, 2018
    Immunotherapy Plus Chemo Improves Survival in Metastatic Lung Cancer
    Immunotherapy

    Immunotherapy Plus Chemo Improves Survival in Metastatic Lung Cancer

    Combining pembrolizumab and platinum chemotherapy plus pemetrexed doubles survival in patients with nonsquamous non-small cell lung cancer (NSNSCLC) without EGFR or ALK gene mutations, according to the results of a study published in the New England Journal of Medicine.

    June 06, 2018
    ASCO Annual Meeting

    Psychological Distress Affects Caregivers but Not Patient Symptoms in Head and Neck Cancer

    Psychological stress in caregivers of patients with head and neck cancer (HNC) may impair the quality of patient care they provide and affect outcomes such as survival. However, patient symptom burden and caregiver tasks and their impact on psychological stress is not well understood.

    June 05, 2018
    ASCO Annual Meeting

    Study Investigates How Health Literacy Affects Adherence to Oral Cancer Medications

    Ensuring patients adhere to oral medications for cancer can be a complex task, especially if patients have low health literacy. Oral medications for cancer continue to be more prevalent, but rates of adherence to oral therapy vary widely by population, cancer type, and level of education. At the 2018 American Society of Clinical Oncology Annual Meeting, researchers presented the results of a study that hypothesized health literacy’s connection to oral medication adherence and whether a multilevel intervention approach would result in greater adherence.

    June 04, 2018
    ASCO Annual Meeting

    Researchers Clarify Connection Between Night Shift Work Duration and the Risk of Colorectal Cancer

    Evidence already supports a connection between night shift work and an increased risk of colorectal cancer (CRC), but the mechanism has been difficult to pinpoint. In a study presented at the 2018 American Society of Clinical Oncology Annual Meeting, researchers evaluated the insulin receptor substrate (IRS) 1 and 2 proteins and presented the role they play in the connection of night shift work and CRC.

    June 03, 2018
    ASCO Annual Meeting

    Early Oncology Care Model Data Show Reduced Hospital Admissions

    Improving quality and reducing costs in a practice are two of the Oncology Care Model’s (OCM) key goals, and one of the best ways to achieve them is to reduce unnecessary emergency department (ED) visits and hospitalizations. During a study presented at the 2018 American Society of Clinical Oncology Annual Meeting, researchers described a campaign implemented to reach those objectives.

    June 02, 2018
    ASCO Annual Meeting

    Patients Report More Satisfaction With Multidisciplinary Care Versus Serial Care for Lung Cancer

    Despite the prevalence of multidisciplinary (MD) care for cancer, rigorous studies comparing it to serial care (SC) are lacking. To address the literature gap, researchers explored the use of MD versus SC for lung cancer and presented the findings at the 2018 American Society of Clinical Oncology Annual Meeting.

    June 02, 2018
    Study Finds That Safety Decreases as Electronic Health Record Capability Increases
    ASCO Annual Meeting

    Study Finds That Safety Decreases as Electronic Health Record Capability Increases

    More needs to be known about how communication challenges and documentation affect ambulatory oncology care. In a presentation on Saturday, June 2, at the 2018 American Society of Clinical Oncology Annual Meeting, researchers revealed study findings about how patient safety is directly affected by electronic health record (EHR) capability and satisfaction, clinician communication, and clinicians’ actions.

    June 02, 2018
    • First page « First
    • Previous page
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Next page
    • Last page Last »
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    • Oncology nurse influence
    View All Topics
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2021 Oncology Nursing Society
     
    Back to Top ▲